CompanyGraph
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 6
- ScaleLevered free cash flow is $57.68M, above the global median of $18.73M
- PositionOperating margin is 36.5%, higher than 95% of its Specialty Chemicals peers (median 6.2%)
- Interpretations11 currently firing — 11
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.86%Above 5Y avg (1.77%)
Annual Rate
JPY 108.00Paid semi-annual
Payout Ratio
26.0%Sustainable
Last Ex-Dividend
Sep 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
112.08BJPY712.41M · vs all stocks (USD)
Trailing P/E
15.85xvs Specialty Chemicals peers
Revenue (TTM)
30.13BJPY191.50M · vs all stocks (USD)
Profit Margin
30.29%vs Specialty Chemicals peers
Beta
1.17xvs all stocks
52-Week Change
23.93%vs all stocks
Forward Annual Dividend Yield
1.86%vs all stocks
Market Capitalization
112.08BJPY712.41M · vs all stocks (USD)
Enterprise Value
120.56BJPY766.31M · vs all stocks (USD)
Trailing P/E
15.85xvs Specialty Chemicals peers
Forward P/E
20.48xvs Specialty Chemicals peers
Price to Sales (TTM)
4.74xvs Specialty Chemicals peers
Price to Book (MRQ)
2.55xvs Specialty Chemicals peers
Enterprise to Revenue
4.00xvs Specialty Chemicals peers
Enterprise to EBITDA
9.18xvs Specialty Chemicals peers
Profit Margin
30.29%vs Specialty Chemicals peers
Operating Margin
36.55%vs Specialty Chemicals peers
Return on Assets (TTM)
13.38%vs Specialty Chemicals peers
Return on Equity (TTM)
17.61%vs Specialty Chemicals peers
Revenue (TTM)
30.13BJPY191.50M · vs all stocks (USD)
Revenue per Share (TTM)
1.22KJPYUpdated Sep 21, 2026Quarterly Revenue Growth
6.50%vs Specialty Chemicals peers
Gross Profit (TTM)
21.01BJPY133.52M · vs all stocks (USD)
EBITDA (TTM)
13.47BJPY85.62M · vs all stocks (USD)
Net Income (TTM)
9.13BJPY58.00M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
2.50%vs Specialty Chemicals peers
Operating Cash Flow (TTM)
9.04BJPY57.45M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
9.07BJPY57.68M · vs all stocks (USD)
Forward Annual Dividend Rate
108.00JPYUpdated Sep 21, 2026Forward Annual Dividend Yield
1.86%vs all stocks
Trailing Annual Dividend Rate
95.00JPYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.63%vs all stocks
5-Year Average Dividend Yield
1.77%vs all stocks
Payout Ratio
25.97%vs Specialty Chemicals peers
Revenue
29.67BJPYFY2026 · Mar 31, 2026Cost of Goods Sold
9.06BJPYFY2026 · Mar 31, 2026Gross Profit
20.61BJPYFY2026 · Mar 31, 2026Operating Income
12.16BJPY77.29M · vs all stocks (USD)
Pre-tax Income
12.57BJPYFY2026 · Mar 31, 2026Income Tax Expense
3.49BJPYFY2026 · Mar 31, 2026Net Income
9.07BJPYFY2026 · Mar 31, 2026EBIT
12.57BJPYFY2026 · Mar 31, 2026EBITDA (Income Statement)
13.47BJPYFY2026 · Mar 31, 2026Other Operating Expenses
4.20BJPYFY2026 · Mar 31, 2026Non-operating Interest Income
127.00MJPYFY2026 · Mar 31, 2026Non-operating Interest Expense
4.00MJPYFY2026 · Mar 31, 2026EPS (Basic)
365.74JPYFY2026 · Mar 31, 2026EPS (Diluted)
365.74JPYFY2026 · Mar 31, 2026Basic Shares Outstanding
24.81MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
24.81MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026Operating Cash Flow
11.92BJPYFY2026 · Mar 31, 2026Free Cash Flow
4.61BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
22.01BJPYFY2026 · Mar 31, 2026Starting Profit (CF Statement)
12.57BJPYFY2026 · Mar 31, 2026Other Non-cash Items
-701.00MJPYFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
584.00MJPYFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-532.00MJPYFY2026 · Mar 31, 2026Capital Expenditures
-7.31BJPYFY2026 · Mar 31, 2026Net Intangibles (CF)
-186.00MJPYFY2026 · Mar 31, 2026Purchase of Investments
-1.00MJPYFY2026 · Mar 31, 2026Sale of Investments
0.00JPYFY2026 · Mar 31, 2026Other Investing Activity
-854.00MJPYFY2026 · Mar 31, 2026Net Investing Cash Flow
-8.16BJPYFY2026 · Mar 31, 2026Long-term Debt Payments
-91.00MJPYFY2026 · Mar 31, 2026Net Short-term Debt Issuance
0.00JPYFY2026 · Mar 31, 2026Common Stock Repurchase
-1.50BJPYFY2026 · Mar 31, 2026Common Dividends Paid
-1.99BJPYFY2026 · Mar 31, 2026Other Financing Charges
-2.00MJPYFY2026 · Mar 31, 2026Net Financing Cash Flow
-3.58BJPYFY2026 · Mar 31, 2026Shares Outstanding
24.62MSharesUpdated Sep 21, 2026Float Shares
15.97MSharesUpdated Sep 21, 2026% Held by Insiders
21.58%vs all stocks
% Held by Institutions
22.71%vs all stocks
Total Cash (MRQ)
22.27BJPY141.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
904.48JPYUpdated Sep 21, 2026Total Debt (MRQ)
32.00MJPY203.40K · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0006xvs Specialty Chemicals peers
Current Ratio (MRQ)
9.38xvs Specialty Chemicals peers
Book Value per Share (MRQ)
2.28KJPYUpdated Sep 21, 2026Total Assets
62.68BJPY398.40M · vs all stocks (USD)
Total Current Assets
39.19BJPYFY2026 · Mar 31, 2026Total Liabilities
8.11BJPYFY2026 · Mar 31, 2026Total Non-current Assets
23.49BJPYFY2026 · Mar 31, 2026Total Non-current Liabilities
544.00MJPYFY2026 · Mar 31, 2026Total Current Liabilities
7.57BJPYFY2026 · Mar 31, 2026Cash & Cash Equivalents
24.23BJPYFY2026 · Mar 31, 2026Accounts Receivable
9.67BJPYFY2026 · Mar 31, 2026Inventory
3.15BJPYFY2026 · Mar 31, 2026Accounts Payable
2.03BJPYFY2026 · Mar 31, 2026Short-term Debt
345.00MJPYFY2026 · Mar 31, 2026Other Current Liabilities
2.60BJPYFY2026 · Mar 31, 2026Long-term Debt
6.00MJPYFY2026 · Mar 31, 2026Other Non-current Liabilities
29.00MJPYFY2026 · Mar 31, 2026Common Stock (Book)
1.28BJPYFY2026 · Mar 31, 2026Retained Earnings
50.10BJPYFY2026 · Mar 31, 2026Total Shareholders' Equity
54.57BJPY346.84M · vs all stocks (USD)
Treasury Stock
5.40BJPYFY2026 · Mar 31, 202652-Week Low
4.20KJPYUpdated Sep 21, 202652-Week High
8.09KJPYUpdated Sep 21, 202652-Week Change
23.93%vs all stocks
Beta
1.17xvs all stocks
50-Day MA
5.88KJPYUpdated Sep 21, 2026200-Day MA
6.13KJPYUpdated Sep 21, 2026Avg 10-Day Volume
87.29KSharesUpdated Sep 21, 2026Avg 30-Day Volume
116.56KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
365.98JPYUpdated Sep 21, 202611 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Cash Elevated Relative to Current Liabilities and Total Assets
Its cash covers more of its near-term bills than in its industry, and is a large share of everything it owns.
Reads
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
Multi-Year Debt Decrease With Cash Near Total Debt And Equity
Long-term debt down in each of four years, and cash now covers most or all of what is left.
Reads
How does this company use capital?
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion Levels
Its gross margin and its cash margin are high for its industry, and its operating margin is high outright.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Three Margin Ratios Elevated Across Gross, Operating, And Net Levels
Its gross and net margins are high for its industry, and its operating margin is high outright.
Reads
ROE, ROA, And Operating ROA Elevated
It earns more on its equity than its industry does, and on its assets too — not on borrowing alone.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is 36.5%, higher than 95% of its Specialty Chemicals peers (median 6.2%)Significant
Operating margin: 0.37Industry median: 0.06Industry P95: 0.22Peers compared: 282
Profit margin is 30.3%, higher than 95% of its Specialty Chemicals peers (median 3.9%)Significant
Profit margin: 0.30Industry median: 0.04Industry P95: 0.17Peers compared: 282
Return on equity is 17.6%, higher than 95% of its Specialty Chemicals peers (median 4.4%)Significant
Return on equity: 0.18Industry median: 0.04Industry P95: 0.17Peers compared: 282
Return on assets is 13.4%, higher than 95% of its Specialty Chemicals peers (median 2.8%)Significant
Return on assets: 0.13Industry median: 0.03Industry P95: 0.11Peers compared: 282
Current ratio is 9.38×, higher than 95% of its Specialty Chemicals peers (median 2.05×)Significant
Current ratio: 9.38Industry median: 2.05Industry P95: 5.89Peers compared: 282
Debt-to-equity is 0×, lower than 95% of its Specialty Chemicals peers (median 0.34×)Notable
Debt-to-equity: 0.00Industry median: 0.34Industry P5: 0.01Peers compared: 282
Financial Health
Altman Z-Score 11.15: safe zoneNotable
Altman Z-Score: 11.15
High earnings qualityNotable
Earnings Quality Score: 0.91
High structural barrier to entryNotable
Barrier to Entry: 0.65
Supply Chain
Downstream position: depends on 10 industries, supplies 6Notable
Outgoing: 6.00Incoming: 10.00
High connectivity hub: 16 industry connectionsNotable
Total Connections: 16.00
Scale
Levered free cash flow is $57.68M, above the global median of $18.73MNotable
Levered free cash flow (USD): 57,677,066.2Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Yuneng Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Argus Shanghai Textile Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Dongguan Golden Sun Abrasives Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Navigation Control Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Lsb Industries Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhang Xiaoquan Inc.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sino-High China Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
PWR Holdings Limited
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Jiangsu Beiren Smart Manufacturing Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Chongqing Qin'an M&E Plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
United States Lime & Minerals Inc.
11 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Nien Made Enterprise Co., Ltd.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesHigh Retained Earnings With Profitability And EquityROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity Configuration
Shanghai MicroPort Endovascular MedTech Co., Ltd.
10 interpretationsThree Margin Ratios Elevated Across Gross, Operating, And Cash-Conversion LevelsMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesROE, ROA, And Operating ROA ElevatedCash-Flow Ratios ElevatedCash Elevated Relative to Current Liabilities and Total AssetsLiquidity Ratios ElevatedIndustry-Benchmarked ROA and Margin ElevatedThree Margin Ratios Elevated Across Gross, Operating, And Net LevelsLow-Leverage Liquidity ConfigurationMulti-Year Debt Decrease With Cash Near Total Debt And Equity
Supply Chain
Petrochemicals Supply Chain
Follow hydrocarbons through cracking, separation, polymers, conversion, use, and recovery. A cracker produces a coupled slate, so feedstock, product demand, contracts, plant configuration, and waste routes constrain one another.
Plastics Supply Chain
Follow feedstock through monomer and polymer production, compounding, conversion, packaging, use, collection, recycling, combustion, and disposal. Resin tonnes and recycling rates are bounded measurements, not proof that the original function returned.
Natural Rubber Supply Chain
Follow natural rubber from tree and tapping through coagulation, grading, compounding, vulcanization, service, and recovery. The chain preserves some properties while closing others, and money arrives on a faster clock than a new stand of trees.